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Abstract.  We have immortalized  rat central nervous 
system (CNS) cells of primary cultures of rat optic 
nerve with murine leukemia virus w2,SV-40-6,  which 
is defective in assembly and contains the SV-40 large 
T antigen and neomycin resistance genes, to produce a 
cell line that we named A7. After drug selection, 
>90%  of the growing cells expressed nuclear SV-40 
large T  cells and a fraction of these contained the 
astrocyte-specific marker,  glial fibrillary acidic protein. 
The majority of these cells also expressed surface 
marker A4 (specific for neural tube derivatives), Ran 
2, p185  (the  185-kD phosphoprotein product of the 
neu oncogene), and fibronectin, but did not express 
the astrocyte enzymes glutamine synthetase and 
monoamine oxidase B.  Surface markers characteristic 
of glial progenitors (A2B5) and oligodendrocytes 
(galactocerebroside) were not detected.  After two 
rounds of cell cloning,  subclone A7.6-3 expressed Ran 
2,  fibronectin, and the neural cell adhesion molecule 
(N-CAM) but not glial  fibrillary acidic protein and A4. 
The A7 cell line and subclones also displayed certain 
functions of type 1 astrocytes: the conditioned medium 
of these cells had a potent mitogenic activity for glial 
progenitor cells which could be neutralized by 
anti-platelet-derived  growth factor antibodies and 
monolayers of these cells supported the growth of 
embryonic hypothalamic neurons.  We conclude that a 
retrovirus containing  SV-40 large T antigen can im- 
mortalize rat CNS cells and that such immortalized 
glial cells retain at least two important  functions of 
type 1 astrocytes: the ability to secrete platelet-derived 
growth factor and to support the growth of embryonic 
CNS neurons.  Moreover, such stable immortalized 
clonal cell lines can be used to study gene regulation 
in glial cells. 
T 
H~ usefulness  of cell lines for the study of neurobio- 
logical  problems has become increasingly  apparent. 
Many cell  lines,  such  as the  C6  glioma  (Benda  et 
al.,  1968),  the  C1300  neuroblastoma  (Augusti-Tocco and 
Sato, 1969), and the PC12 pheochromocytoma (Tischler and 
Greene,  1978) have been derived by placing spontaneous or 
chemically induced tumors into cell culture.  By continuous 
passage,  subculturing,  and selection,  cell lines with specific 
phenotypes have been isolated and characterized,  and they 
have been used to study these specialized properties.  On the 
other hand,  many of the subclones of these tumor-derived 
cell lines are not stable, and sometimes the phenotypic prop- 
erties of the line are not expressed by all of the cells within 
any clone. 
It would obviously be desirable to have  glial  cell  lines 
which display cell-type specific properties, but whose origin 
and growth are more closely controlled.  One way in which 
to accomplish this  is to express the immortalizing  protein 
product of an oncogene in otherwise normal  cells.  Under 
these circumstances,  one might expect that at least some of 
the phenotypic properties of  the parent cell would be retained 
and could be studied more intensively at both the molecular 
and  functional  level than  would be possible with primary 
cells. Several glial and neuronal cell lines have already been 
produced by such methods,  with varying degrees of preser- 
vation  of phenotypic properties.  In human  astroglial  cells 
that were transformed by SV-40 large T antigen (Major et al., 
1985), glial fibrillary  acidic  protein  (GFAP), j the interme- 
diate filament protein of astrocytes, continued to be expressed 
in the transformed  cells.  A similar technique  has been used 
to insert the SV-40 large T antigen into rat astrocytes where 
two clones expressing  immunological  and pharmacological 
properties of astrocytes  were isolated  (Neto et al.,  1986). 
1. Abbreviations  used in this paper:  CM, conditioned medium; CNS, cen- 
tral nervous system; GC, galactocerebroside; GFAP, glial fibrillary acidic 
protein; N-CAM, neural cell adhesion molecule; PDGF, platelet-derived 
growth factor. 
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ously with the polyoma virus large T and the Neo R genes 
(Evrard et al., 1986). This procedure resulted in immortal- 
ized glial cells that did not fully assume a transformed phe- 
notype; although GFAP was not expressed in most of these 
cell lines,  it was  sometimes reinduced by procedures that 
promote differentiation (Evrard et al.,  1986).  Transforma- 
tion of nerve cells has been obtained with temperature sensi- 
tive mutants of Rous sarcoma virus and SV-40 (Pessac et al., 
1983;  Mallat et al.,  1986). 
In the experiments described here,  we used a  retroviral 
vector containing the SV-40 large T antigen and the neomy- 
cin resistance gene Oat et al.,  1986) to immortalize a cul- 
tured rat glial cell, with the goal of producing a cell line that 
maintains glial-specific properties.  We were especially in- 
terested in immortalizing the bipotential O-2A  progenitor 
(Raff  et al., 1983) or the type 1 astrocyte. The O-2A progeni- 
tor can differentiate into either an oligodendrocyte or a type 
2 astrocyte, depending on culture conditions, whereas the 
type 1 astrocyte stimulates the mitosis of the O-2A progeni- 
tors (Noble and Murray, 1984).  Characterization of the ini- 
tial immortalized cell line after drug selection indicated an 
astrocytic, rather than O-2A lineage, origin. After subclon- 
ing, ceils continued to display a phenotype resembling, but 
not identical with, type 1 astrocytes. However,  they main- 
tained  two  important  functions of type  1 astrocytes:  the 
ability to synthesize platelet-derived growth factor (PDGF) 
(Richardson et al., 1988) and to support the growth of central 
nervous system (CNS) neurons (Fallon,  1985;  Ventimiglia 
and Geller,  1987). 
Materials and Methods 
Immortalization of  Glial Cells 
Purified type 1 astrocytes were prepared as described (Noble and Murray, 
1984),  seeded in 60-ram Petri dishes, grown to confluence in DME sup- 
plemented with 10%  FCS and antibiotics, and then irradiated with 3,000 
fads to eliminate mitosis.  The  medium was changed to  a  modified N2 
medium  (Bottenstein  and  Sato,  1979)  supplemented  with  0.5%  FCS 
(N2/FCS) (Raffet al., 1983) 3 d before seeding optic nerve cells from new- 
born rats obtained by enzymatic dissociation (Raft et al.,  1983).  The latter 
were allowed to grow on the type 1 astrocyte monolayer for 1 d before viral 
infection. 
A W-2 cell line that stably produces a defective recombinant retrovirus 
SV-40-6 containing the neomycin resistance and SV-40 large T genes Oat 
et al.,  1986) was kindly provided by C. Cepko, Harvard Medical School, 
Boston, MA (Cepko et al., 1984). 24-h conditioned N2/FCS medium from 
the q/-2 cells was collected, filtered through a  0.45  laM filter (Millipore 
Corp., Bedford, MA), and added to the glial culture at 37°C in the presence 
of 4  lag/ml of Polybrene. After 4  h,  the W2  medium was removed and 
replaced by N2/FCS.  20 d  later,  a very large number of process-bearing 
oligodendrocyte-like cells  could  be  identified  on  the  type  1  astrocyte 
monolayer. The N2/FCS was then replaced with DME containing 10% FCS 
(DME/FCS) and 1 mg/ml G418 in order to select cells that had integrated 
the retrovirus construct DNA and were, therefore, resistant to this drug. The 
drug was left on for 10 d, then removed, and the remaining growing cells 
were expanded in plastic flasks in DME/FCS. Cells grew rapidly and were 
mostly flat (Fig.  1). They did not pile up and their doubling time was 2-3 d. 
After this astroglial cell line (A7) was characterized (see Results) and passed 
six times, we subcloned the cells by limiting dilution in 96-well plates. New 
clones, developed after 10 d to 2 wk, were expanded. 
The second cloning was done in a  similar manner, starting from one 
selected clone (A7-6) which secreted the highest amount of mitogenic activ- 
ity for O-2A progenitors (see below). One of the subclones (A7-6.3) has now 
been passed 14 times and displayed stable growth and mitogenic activity in 
its supernatant through these passages even after the cells had been frozen 
and thawed.  After the fifteenth passage,  however, cells tend to become 
confluent more rapidly.  Therefore, large stocks of a fifth passage of A7-6.3 
were frozen in DMSO, stored in liquid nitrogen, and thawed when needed. 
Immunofluorescence 
Various antibodies were used to identify the nature of the A7 cells and char- 
acterize them in double-labeling experiments. Cells were grown on 13-ram 
glass coverslips and used in log-phase growth. Staining for surface antigens 
was conducted on live cultures, or cultures fixed for 5 rain in 4% parafor- 
maldehyde in PBS. Staining for intracellular antigens was conducted on cul- 
tures fixed in 5 % acetic acid in ethanol for 5 min at -20°C and then rinsed 
with serum containing medium, mAbs used included L19 directed against 
SV-40 large T  antigen (kindly provided by Dr.  D.  Latchman,  University 
College, London, UK); A4 (Cohen and Selvendran,  1981; Miller et al., 
1984);  Ran  2  (Bartlett  et  al.,  1981); A2B5  (Eisenbarth  et  al.,  1979); 
anti-galactocerebroside (GC; Ranscht et al.,  1982);  R'197 anti-neurofila- 
ment (Wood and Anderton, 1981); and anti-fibronectin kindly provided by 
Dr. Rhona Mirsky, University College, London. Rabbit polyclonal antibod- 
ies used included anti-GFAP (Bignami et al., 1972); anti-fibronectin (Price 
and  Hynes,  1985);  and  anti-neural  cell  adhesion  molecule  (N-CAM) 
(Chuong et al., 1982). Each primary antibody was followed by an appropri- 
ate fluorescent conjugate purchased from either Cappel Laboratories (MaP 
vern, PA) or Nordic Immunology (Capistrano Beach, CA). In double-label 
experiments, the surface antibody and its conjugate were initially applied; 
cultures were then fixed in acid alcohol and the intracellular antigen was 
decorated. For double-labeling with mAbs A2B5 and anti-GC, the cells 
were  initially  reacted  with  antibody  A2B5,  followed  by  rhodamine- 
conjugated goat anti-mouse IgM; the next incubation was with anti-GC fol- 
lowed by fluorescein-conjugated rabbit anti-mouse IgG3. Cultures were ob- 
served with a standard or universal microscope (Carl Zeiss, Inc., Thorn- 
wood, NY) equipped with epifluorescence illumination. 
For flow cytometric analysis of surface antigen expression, cells were 
grown in 75-cm  2 tissue culture flasks and harvested in log phase growth. 
Cells were suspended at a concentration of 3  x  106 cells/ml in balanced 
salt solution with 10% FCS containing mAb 7.16.4 directed against the 185- 
kD cell surface glycoprotein expressed by the neu oncogene (Drebin et al., 
1984) at a concentration of 50 I.tg/ml for 30 min at 4°C. Cells were washed 
twice in balanced salt solution and resuspended in goat anti-mouse Ig-FITC 
(Cappel Laboratories) for a further 30 min at 4°C. Nonspecific binding was 
measured by omitting the primary antibody. Cells were also incubated with 
the vital dye propidium iodide to control for viability.  After washing, cells 
were analyzed using a flow cytometer (Epics 5; Coulter Electronics Inc., 
Hialeah, FL). 
Enzyme Assays 
Glutamine synthetase and monoamine oxidase activities were kindly mea- 
sured in the laboratory of Dr.  W. Nicklas, Robert Wood Johnson Medical 
School (Piscataway,  NJ).  Glutamine synthetase was measured by a modi- 
fication of the method of Patel et al. (1982).  Monoamine oxidase activity 
was determined radioenzymatically using a modification of the method of 
White and Stine (1984).  Protein was determined by the method of Lowry 
et al.  (1951). 
Test System  for O-2A Progenitor Cell Mitosis 
Optic nerves from 7- or 9-d-old rats were enzymatically dissociated and 
plated onto polylysine-coated glass coverslips at 2-5  ×  103 cells/coverslip 
and grown in defined medium (Raffet al.,  1983).  A7 conditioned medium 
(CM) was obtained by growing A7 cells in DME with 2 or 10%  FCS for 
24-48 h. Test medium consisting of a 1:5 dilution A7 CM was added to the 
optic nerve cultures; control medium was supplemented with 0.5 to 2 % FCS 
to match the fnal serum concentration with that of the test medium. Half 
of the test medium was renewed with fresh CM every day or at least once 
during the 3 d of culture. In some experiments, we compared the activity 
of these CMs with that of porcine PDGF, known to be devoid of transform- 
ing growth factor I~ activity (Bethesda Research Laboratories, Gaithersburg, 
MD; test kindly performed in the laboratory of Dr.  A. Roberts, National 
Institutes of Health [NIH], Bethesda, MD). 
After 3 d, cells were double-labeled with anti-GC and A2B5. Alternately, 
cells were labeled with A2B5 followed by GFAP as described above. Oli- 
godendrocytes are identified as the GC + population, whereas O-2A pro- 
genitors are identified as the A2B5  +, GC- population of cells (Raft et al., 
1983).  When [3H]thymidine  was used, cultures were labeled from 24 to 
48 h with 0.05 ~tCi/ml of [3H]thymidine  (New England Nuclear, Boston, 
The Journal  of Cell Biology,  Volume  107, 1988  1978 MA;  act 52  Ci/mmol) before being fixed and immunolabeled as above. 
NTB-2 emulsion was applied to the stained coverslips at 4°C for 3 d and 
autoradiograms were developed following standard procedures. When auto- 
radiography was combined with double labeling, all O-2A lineage cells in 
20-50  microscopic fields were counted in  each  experimental condition 
(using a 40x  oil objective) and the percent of thymidine-labeled cells in 
each cell population (oligodendrocytes or progenitors) was calculated. 
Neutralization of  Mitogenic Activity of 
A7-63 Supernatants 
The neutralization potency of purified IgG fractions of antibody to human 
PDGF (Collaborative Research, Inc., Waltham,  MA) against A7-6.3 CM 
stimulation of progenitor cell mitosis was compared to that against porcine 
PDGE Anti-PDGF antibody at a concentration of  40 gg/ml (known to neu- 
tralize most PDGF mitogenic activity on NIH 3T3 cells) was added to cul- 
tures of 9-d-old rat optic nerve along with serial dilutions of A7-6.3 CM and 
the mitosis assay was carded out as described. The cells were carefully 
washed of debris before being refed with antibody-containing medium at 
2d. 
Glial Growth Factor Activity 
CM from cell line A7-6.3 was tested for glial growth factor activity by Dr. 
J.  Brockes at Kings College, London, England, as previously described 
(Brockes et al.,  1980). 
Neuronal Growth Assay 
A7 cells were plated onto polylysine-coated  coverslips and allowed to grow 
to near confluence. Embryonic day  17  hypothalamic neurons were then 
plated onto the monolayers, and the growth and attachment of the neurons 
was monitored using phase-contrast and modulation-contrast microscopy 
(Ventimiglia and Geller,  1987).  At time periods of 1, 3, and 7 d, cultures 
were removed and labeled for neurofilament protein using mAb RT97. 
Results 
Initial Growth 
No acute cytopathic effects were observed in the cultures af- 
ter exposure to the virus. Over the initial several weeks after 
virus exposure,  cultures  grew normally;  there were many 
phase-bright,  round,  process-bearing  cells  (presumptive 
O-2A glial progenitors and oligodendrocytes) on top of the 
astrocyte monolayer. The number of these phase-bright cells 
continued to increase with time in culture. After 3 wk in cul- 
ture,  an area  of enhanced  growth  was  detected  by phase- 
contrast microscopic observation of the  culture  dish.  The 
culture medium was then replaced with DME/FCS contain- 
ing G418 (neomycin) at a concentration of 1 mg/ml for 10 d. 
All of the phase-bright cells were killed by the drug, while 
a population of drug-resistant flat cells survived and grew. 
These flat cells were then expanded in tissue culture flasks, 
and then refed twice a week. The growth of these cells was 
a function of the serum concentration in the medium: cells 
grown in DME/FCS  grew more rapidly than those in N2/ 
FCS. Cells were therefore grown in DME/FCS and passaged 
at confluence. These passaged cells (named A7 and charac- 
terized here) were then plated onto coverslips for immunocy- 
tochemical characterization. 
The population of A7 cells, although polymorphic, were 
mostly flat (Fig.  1)  and resembled cultured  cortical astro- 
cytes in serum-containing medium (McCarthy and de Vellis, 
1980). Neither the A7 cell line nor the subclones showed foci 
formation or  loss  of contact inhibition.  Cells  had  a  rapid 
growth rate and doubled in 2-3 d.  Although we did not test 
tumorigenicity of our cell lines, other SV-40 large T antigen- 
Figure 1. Morphology of A7 cells. Phase-contrast photomicrograph 
of living A7 cells grown in serum-containing medium in a 35-mm 
plastic tissue culture dish.  Cells grow individually  and are rela- 
tively fiat, and demonstrate clear cytoplasm. Bar, 50 lxm. 
expressing cell lines obtained with the same murine retro- 
virus shuttle vector are not tumorigenic (Jat et al.,  1986). 
Antigenic Characterization 
First passage A7 cells were stained for SV-40 large T antigen 
and 95-98% of the cells expressed this transforming gene in 
their nucleus (Fig. 2 E). These cells were also stained with 
other  antibodies to detect  specific markers for astrocytes, 
oligodendrocytes, and O-2A progenitors (Table I). The A7 
cell  line  did  not  express  the  antigen  recognized  by  mAb 
A2B5 nor GC, therefore excluding the possibility that these 
immortalized cells were O-2A progenitor cells, type 2 astro- 
cytes, or oligodendrocytes. In contrast, the cells stained with 
antibodies to several other surface markers characteristic of 
type 1 astrocytes: A4, an mAb which reacts with neural tube 
derivatives (Cohen and Selvendran, 1981; Miller et al., 1984), 
and Ran 2 and fibronectin which are normally present on both 
type 1 astrocytes and meningeal cells (Bartlett et al.,  1981; 
Price and Hynes, 1985).  Unfixed cells labeled with anti-N- 
CAM showed a bright surface fluorescence. Fibronectin had 
a fibrillar rather than the punctate pattern described in nor- 
mal type  1 astrocytes (Fig.  2). 
A fraction of the A7 cells initially expressed GFAP, but the 
GFAP was diffuse in  the cell cytoplasm in  contrast to the 
filamentous pattern seen in normal type 1 astrocytes. This 
expression of GFAP was lost after several passages of the 
cells.  To test the possibility that the cells expressed GFAP 
which did not polymerize correctly, we also performed im- 
munoblots on extracts of A7 cells using the same anti-GFAP 
antibody. No GFAP expression was detected. In addition, we 
did not see an increase in GFAP expression when cells were 
treated with either dibutyryl cAMP or retinoic acid to en- 
hance differentiation (data not shown). 
We also examined this cell line for the production of gluta- 
mine synthetase and monoamine oxidase B,  enzymes nor- 
mally found in type 1 astrocytes (Patel et al.,  1982;  Levitt 
et al.,  1982). The level of expression was below the limit of 
the assay, whereas levels in parallel cultures of type 1 astro- 
cytes were found to be  1.5  ~tmol/mg protein per hour for 
Geller and Dubois-Dalcq  Characterization of Immortalized Glia  1979 Figure 2. Antigenic  characterization  of the A7 cells.  (A and B) Double immunocytochemistry illustrating  the same field illuminated  with 
rhodamine optics demonstrating A4 immunoreactivity (B) and fluorescein optics demonstrating  the GFAP staining (A). (C and D) Double 
immunocytochemistry illustrating  the same field stained for the surface marker Ran 2 under rhodamine optics and GFAP staining revealed 
with fluorescein.  Note that some GFAP positive cells do not display Ran 2 reactivity. (E) Staining with mAb L19 for SV-40 large T antigen 
shows reactivity  in the nuclei  of most cells.  (F) Staining  with mAb to fibronectin  illustrates  the fibrillar  organization of fibronectin  on 
the cell  surface.  Bar,  50 Ixm. 
glutamine synthetase and 100 pmol/mg protein per hour for 
monoamine oxidase B (Farinelli,  S., and D. Panek, personal 
communication). 
Flow cytometric analysis after immunolabeling with mAb  A7  A7-6.3  Type l 
Antigen/enzyme  cell line  cell line  astrocytes  7.16.4 (Drebin et al.,  1984) was used to examine the expres- 
sion  of the  neu  oncogene  receptor  phosphoprotein,  p185  A2B5  .... 
(Schechter et al.,  1984), by the A7 cell line. For comparison,  GC  .... 
we also stained cultures of primary type 1 astrocytes derived  GFAP  +  -  + 
form rat cerebral cortex and C6 glioma cells  (Fig.  3).  The  Ran 2  +  +  +§ 
analysis of these histograms demonstrated that 95 %  of A7  Fibronectin  +  +  +  II 
cells  and  C6 astrocytoma cells  showed a  specific reaction  A4  +  -  +~ 
N-CAM  +  +  +  ** 
with antibody 7.16.4, while over 70% of the primary rat cor-  p185  +  ND  + 
tical astrocytes reacted with this antibody.  Glutamine synthetase  -  ND  +~ 
Because the A7 cell line appeared heterogenous, we cloned  Monoamine oxidase B  -  ND  + §§ 
the cells twice successively. Subclones had lost the expres-  Supports neural outgrowth  +  ND  + Illl 
sion  of GFAP  and  of the  neural  tube  marker  A4.  These 
cloned cells were SV-40 large T, Ran 2, and fibronectin posi- 
tive and also expressed  N-CAM (Table I). 
Table L Characteristics of  lmmortalized Cells Derived  from 
Rat CNS as Compared with Type 1 Astrocytes 
* Raffet al.,  1983; ~ Bignami et al.,  1972; § Bartlett et al.,  1981;  II Price and 
Hynes,  1985; I  Miller et al.,  1984; ** Noble et al,,  1985; ~:~ Pishak and Phil- 
lips,  1980;  §§ Levitt et al.,  1982;  1111 Fallon,  1985. 
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Figure 4. Ratio of oligodendrocytes to progenitors after 3 d of optic 
nerve culture  in the presence  or absence of conditioned medium 
from A7 and A7.6-3 cell  lines.  Progenitors  and oligodendrocytes 
were counted in duplicate coverslips as described in Materials and 
Methods and their respective ratios were calculated.  Open boxes, 
% oligodendrocytes (galactocerebroside+); hatched boxes, % pro- 
genitor cells (A2B5  +, galactocerebroside-). 
Figure 3. Flow cytometric analysis of mAb 7.16.4 binding to (a) A7 
cells,  (b) C6 glioma cells,  or (c) primary type 1 astrocytes. Un- 
hatched histograms represent background fluorescence of the fluo- 
rescent  conjugate in the absence of primary antibody, while the 
hatched histograms represent fluorescence after treatment with the 
primary and secondary antibodies. Analysis of  these histograms in- 
dicates that 95% of the A7 and C6 cells are positive for 7.16.4 bind- 
ing, whereas 65 % of the primary astrocytes are positive. 
Mitogenic Activity of the Supernatant 
Since the A7 cell line expressed certain markers characteris- 
tic of type  1 astrocytes,  we tested whether these cells ex- 
pressed and secreted a mitogenic activity for O-2A progeni- 
tor  cells  from  rat  optic  nerve  (Raft et  al.,  1983).  O-2A 
progenitor cells were obtained from 7-d rat optic nerve (No- 
ble and Murray,  1984) and cultured in the presence or ab- 
sence of 24-h A7 CM diluted  1:5 in defined medium. After 
3 d, cultures were immunolabeled for A2B5 and GC. Total 
O-2A lineage cells (all cells expressing either A2B5 or GC) 
were counted on duplicate coverslips and the ratio of GC  + 
oligodendrocytes to A2B5+/GC  - progenitor cells was calcu- 
lated (Fig. 4).  In defined CM, 95 % of the cells were GC  + 
oligodendrocytes whereas close to 50% of the O-2A lineage 
cells grown in CM were A2B5 +, GC- progenitors. 
After two rounds of cell cloning, we obtained two cell lines 
with increased mitogenic activity in their supernatant.  One 
of these clones (A7-6.3)  is illustrated in Fig. 5. After 3 d in 
A7-6.3  CM (containing  10%  FCS and diluted  1:5),  70% of 
total O-2A cells were progenitors; the remaining cells were 
oligodendrocytes  indicating  that  differentiation  could  take 
place in the presence of this mitogen. CM containing  10% 
serum was found to be more mitogenic than CM with 2 % 
FCS, and mitogenic activity was found in 24-h defined CM 
without serum, although in lesser amounts (data not shown). 
Since '~1/3 of the cells in a suspension of 7-d-old optic nerve 
are progenitors (Noble and Murray,  1984),  we could esti- 
mate the number of progenitors per coverslip at the time of 
dissociation.  Taking the ratio of the number of progenitors 
at 3 d to the initial number, we calculated that addition of A7 
CM resulted in an approximately two doublings of the pro- 
genitor population in 3  d,  whereas addition of A7-6.3  CM 
produced  approximately four doublings  in  3  d.  Total cell 
population  was  also  increased  fourfold  compared  to  un- 
treated cells at 3 d. 
Another  clone  (A7-6.1) had  slightly  different  properties 
than A7-6.3. A7-6.1 CM also caused striking proliferation of 
progenitors; after 3 d, 67 % of the total population were pro- 
genitors.  However, only  15%  of the remaining O-2A cells 
were oligodendrocytes (in contrast to 30% oligodendrocytes 
with  A7-6.3  clone)  while  18%  of the  cells  were  A2B5  ÷, 
GFAP  + type 2  astrocytes. Thus,  the A7-6.1 clone may syn- 
thesize not only mitogens for the O-2A progenitors but fac- 
tors inductive of type 2  astrocyte differentiation. 
The mitogenic effect of A7-6.3  CM  was further demon- 
strated by [3H]thymidine incorporation combined with dou- 
ble immunolabeling.  CM activity was compared to that of 
PDGF,  which displays strong mitogenic activity for O-2A 
progenitors (Richardson et al.,  1988). The results of this ex- 
periment are presented in Table II. The mitogenic activity of 
2% serum CM diluted 1:5 (final serum concentration 0.4%) 
was similar to the activity of 25 ng/ml porcine PDGF in 0.5 % 
serum medium; '~50 % of progenitor cells had incorporated 
Geller  and  Dubois-Dalcq  Characterization of Immortalized Glia  1981 Figure 5. Representative fields of optic nerve cells cultured 3 d in the presence (A) or absence (B) of A7.6-3 CM. In the presence of CM, 
the majority of the cultured cells are bipolar progenitors as revealed with antibody A2B5 (A), while most cells are oligodendrocytes when 
reacted with anti-GC antibody (B) with no added CM.  These results are quantitated in Fig. 4.  Bar, 20 ~tm. 
[3H]thymidine  in  the  period  immediately before  fixation. 
Rarely were oligodendrocytes observed to undergo mitosis, 
and those were only immature oligodendrocytes  (cells la- 
beled both with anti-GC and A2B5). 
To determine if the mitogenic activity of A7-6.3  CM was 
due to PDGF-like molecules, we tested the ability of a goat 
polyclonal anti-human PDGF antibody to inhibit progenitor 
cell mitosis. We compared it to the ability of the same anti- 
body to neutralize O-2A progenitor mitosis triggered by por- 
cine  PDGF  (Table III). At a  dilution  of 1:20, 95%  of the 
mitogenic activity of A7-6.3  CM was neutralized;  this was 
progressively diminished with increasing concentration of A7- 
6.3 CM. Porcine PDGF activity was also substantially neu- 
tralized by our antibody. These results suggest that PDGF is 
the major factor responsible for progenitor cell mitosis in- 
duced by A7-6.3  CM. 
None of our clones were found to secrete glial growth fac- 
tor activity as tested on Schwann cells (Brockes,  1980). 
Growth of Neurons on A7 Cells 
One characteristic of type 1 astrocytes is the ability to sup- 
port  neuronal  adhesion  and  neuritic  outgrowth.  Hypotha- 
lamic neurons dissociated from embryonic rats are strongly 
dependent on the astrocyte monolayer for their survival and 
growth  (Ventimiglia  and  Geller,  1987),  and  we  therefore 
used a similar protocol to assess the ability of the immortal- 
ized cells to support neuronal growth. Neurons plated onto 
a  monolayer of A7 cells remained as isolated neurons and 
showed little evidence of clumping. Neuritic outgrowth from 
these neurons was apparent as early as 1 d after plating, and 
by 7 d the neurons demonstrated significant neurite outgrowth 
as visualized by anti-neurofilament antibody (Fig.  6).  The 
neurites showed little evidence of fasciculation and generally 
rambled on the surface of the A7 monolayer as isolated pro- 
cesses. The neurites tended to be of smaller caliber than neu- 
rites which grew on parallel cultures plated onto type 1 astro- 
cytes.  Neuronal  survival on A7 cells was somewhat lower 
than  neurons  plated  onto primary type  1 astrocytes.  This 
lower survival appeared to be due to the high metabolic rate 
of the A7 monolayer which necessitated frequent media ex- 
change; our previous results indicate that hypothalamic neu- 
rons do not benefit from frequent feeding (Ventimiglia and 
Geller,  1987). 
Table II.  Tritiated Thymidine Incorporation  by O-2A 
Progenitors 
Addition to culture medium 
[3H]thymidine-labeled  nuclei  (%) 
Progenitor cells  Oligodendrocytes 
None  3  1.25 
Porcine PDGF  (25  ng/ml)  47.5  2 
A7-6.3  CM  45.5  0.5 
A 1:5 dilution of A7-6.3  CM was added to cultures of 7-d-old optic nerve, and 
the numbers  of cells incorporating [3H]thymidine were counted.  Values given 
are means of two experiments. 
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Number of progenitors/coverslip 
Addition  Concentration  Without antibodies  With antibodies  Neutralization (%) 
None  1  ND 
Porcine PDGF  12.5  ng/ml  29  4.5  87 
A7-6.3 CM diluted  1:5  155  155  0 
1:10  150  62  59 
1:20  175  10  95 
Porcine PDGF or A7-6.3 CM with or without  anti-PDGF antibodies  were added to cultures of 9-d-old rat optic nerve and the numbers  of progenitors were counted 
on day 3. Anti-PDGF antibodies were added at the time of dissociation and on day 2. 
Discussion 
We describe here the antigenic and biological properties of 
a cell line derived from rat CNS cells after infection with a 
murine recombinant retrovirus containing the SV-40 large T 
transforming gene (Jat et al.,  1986). Our goal was to immor- 
talize glial cells in order to allow an approach to the control 
of expression of cell-type specific properties of glial cells. 
We expected that, since our primary culture was comprised 
of type 1 astrocytes and O-2A progenitors, the immortal cell 
would resemble one phenotype or another.  In fact, the A7 
cell line that we have obtained, as well as its subclones, ex- 
Figure 6. Growth of embryonic hypothalamic neurons on A7 cells. (A) Phase-contrast and (B) fluorescence photomicrographs after decora- 
tion with anti-neurofilament antibody of several neurons on a monolayer of A7 cells 24 h after plating, showing isolated cell bodies and 
processes. (C) Modulation-contrast  photomicrograph of living neurons 3 d after plating on a monolayer of A7 cells, showing thick processes 
rambling over the monolayer. (D) High-power differential interference-contrast  photomicrograph of several neurons 7 d after plating on 
the A7 monolayer. Bars:  (A-C) 50 I.tm; (D) 25  ~tm. 
Geller and Dubois-Dalcq Characterization of Immortalized Glia  1983 presses properties reminiscent of type 1 astrocytes (Table I). 
Similarly to type 1 astrocytes, both the A7 cell line and sev- 
eral subclones support the growth of dissociated embryonic 
neurons and secrete PDGE The A7 line also expresses high 
levels  of the p185 phosphoprotein product of the neu  on- 
cogene, which is expressed by primary type 1 astrocytes in 
culture, and is a characteristic of many neuroblastoma and 
glioblastoma cell lines (Schechter et al., 1984). In addition, 
the expression of  GFAP, the major intermediate filament pro- 
tein of astrocytes, and the neural tube marker A4, were de- 
tected in early passage cells, but this expression was lost with 
passage. No properties of O-2A lineage cells are expressed 
by A7 cells. The reason why no O-2A lineage cell lines were 
established is obscure: O-2A progenitors may not have been 
present in sufficient numbers to be affected by the virus, or 
may not have been receptive to the insertion of the virus. 
The reasons why GFAP expression and the neural tube 
marker A4 were lost in our immortalized cell line are unclear. 
It is possible that the cell we have immortalized is not an as- 
troglial cell; this seems unlikely based on the initial expres- 
sion of GFAP and A4. The other possibility is that the im- 
mortalization resulted in the loss of astrocyte-specific gene 
expression  in  those type  1 astrocytes having the  highest 
growth potential.  Other  virus-transformed glial cell lines 
have demonstrated variable levels of GFAP expression, from 
very low (Neto et al., 1986) to high (Alliot and Pessac, 1981); 
however,  the level of GFAP expression was not correlated 
with doubling time in these earlier experiments.  The C6 
astrocytoma cell line expresses low levels of GFAP under 
normal growth conditions, but, similarly to normal type 1 
astrocytes (Goldman and Chiu, 1984),  GFAP expression is 
dramatically increased in C6 cells by exposure to dibutyryl 
cAMP (Raju et al., 1980).  Neither dibutyryl cAMP nor ret- 
inoic acid increased GFAP expression by A7 cells. An in- 
verse  correlation between  growth  potential and cell-type 
specific gene expression would also explain the absence of 
detectable glutamine synthetase and monoamine oxidase B 
activity in A7 cells. Glutamine synthetase activity in low pas- 
sage C6 cells is relatively low as compared to primary astro- 
cytes, and can be increased by dibutyryl cAMP (Browning 
and Nicklas, 1982) and glucocorticoids (Pishak and Phillips, 
1980). Thus, the A7 cell line resembles the C6 cell in basal 
conditions, but does not respond to hormonal stimulation. 
The expression of the neural tube marker, A4, by these 
cells is also interesting. A4 was originally described as hav- 
ing a distribution limited to CNS neurons in culture (Cohen 
and Selvandran, 1981). Later experiments demonstrated that 
A4 was also expressed by all astrocytes in vivo and both type 
1 and type 2 astrocytes in culture, although the expression 
on type 1 astrocytes was low after several  days in culture 
(Miller et al.,  1984).  Human astrocytomas have recently 
been shown to express A4, with a high degree of correlation 
of expression of GFAP and A4 (Rettig et al., 1986). Few as- 
trocytomas which expressed only A4 or GFAP were iden- 
tified, leading to the conclusion that A4  is a  marker for 
differentiated tumor cells.  Our results are consistent with 
this observation, since the expression of A4 and GFAP by the 
A7 cell line and its progeny appear to be coordinated, in that 
the early passage cells expressed both markers while later 
passage cells express neither. One other characteristic of A7 
cells is that they have fibrillar fibronectin on their surface. 
The dual or alternate expression of GFAP and fibronectin has 
been described in glioma cells (Bigner et al., 1981). Fibro- 
nectin is usually synthesized in a nonfibrillar form by type 
1 astrocytes (Price and Hynes, 1985). 
Both A7 cells and C6 cells expressed high levels  of the 
p185 phosphoprotein product of the neu  oncogene; primary 
cultured astrocytes were also positive, but at a lower level of 
expression. The neu oncogene, also known as c-erbB-2 (Ya- 
mamoto et al., 1986) and HER2 (Coussens et al., 1985), was 
identified by transfection of DNA extracted from chemically 
induced neural and glial tumors into NIH 3T3 cells (Shih et 
al.,  1981). mAb 7.16.4 was developed by immunizing mice 
with one of these transfected cell lines (Schechter et al., 
1984); this antibody was found to react specifically with p185 
(Drebin  et al.,  1985).  p185 is  structurally related to the 
epidermal growth factor receptor,  and also possesses tyro- 
sine kinase activity (Stern et al., 1986). Recent studies have 
shown that neu expression is elevated in a variety of normal 
embryonic tissues, including the nervous system, connective 
tissue, and secretory epithelium; this expression is not ap- 
parent in adult tissue (Kokai et al., 1987). This suggests that 
c-neu  may be involved with normal growth control in em- 
bryonic development. That both A7 and C6 cell lines strong- 
ly express p185, coupled with the fact that there is a high level 
of expression by cultured primary rat cortical astrocytes, 
would support the role of the p185 phosphoprotein in growth 
control. Further support for the correlation between c-neu 
expression and mitosis is that cultured primary astrocytes, 
which  continue  to  be  mitotically  active,  express  p185, 
whereas adult astrocytes in situ do not (Kokai et al., 1987). 
The potent mitogenic activity for O-2A progenitors se- 
creted by A7 and A7-6.3 cells closely resembles that secreted 
by type 1 astrocytes (Noble and Murray, 1984). The type 1 
astrocyte-derived mitogenic factor comigrates with human 
PDGF on a size-exclusion column and, when reduced, yields 
the A and B chain of PDGF (Richardson et al., 1988). Both 
type 1 astrocytes and A7o6.3 cells synthesize the major PDGF 
A-chain transcript as well as low levels  of PDGF B-chain 
transcripts (Richardson et al., 1988). PDGF transcripts can 
be detected in rat brain during gliogenesis. These studies 
would thus support a role for PDGF secreted by type 1 astro- 
cytes in the stimulation of the division of O-2A progenitors 
during CNS gliogenesis. 
The fact that A7 cells support the growth of embryonic 
hypothalamic neurons would lend further support to the as- 
trocyte character of this cell line. Hypothalamic neurons ap- 
pear to require an astrocyte monolayer for attachment and 
neuritic outgrowth; very poor survival was observed when 
neurons were plated onto other substrates, such as fibronec- 
tin, polylysine, or laminin (Ventimiglia and Geller,  1987). 
It is thus unlikely that the fibronectin associated with the A7 
cell surface would support the extent of neuronal growth ob- 
served here. The majority of neurons plated on a monolayer 
of A7 cells exhibited visible neurites by 24 h in culture, and 
continued to grow for several  weeks after plating. Further- 
more, neurons plated on the A7 substrate, as on astrocytes, 
generally remained as single units, with little evidence of 
neurite fasciculation. This property has been attributed to the 
presence of N-CAM on the surface of astrocytes (Noble et 
al.,  1985);  A7 cells and the A7-6.3 subclone express  im- 
munologically identified N-CAM  on  their  surface  which 
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talized cells may serve as a ready source of feeder cells for 
studies of dissociated neurons in culture. 
In summary,  retroviral infection of primary  rat glial cells 
by a virus containing SV-40 large T antigen has produced an 
immortal cell line with a mixed astrocytic phenotype.  This 
mixed phenotype is likely to be a characteristic  of incom- 
pletely differentiated  cells, thus suggesting that the insertion 
of an immortalizing oncogene may disrupt terminal differen- 
tiation while promoting cellular division. On the other hand, 
some important  functional properties of type  1 astrocytes, 
such as the synthesis of PDGF and the ability to support neu- 
ronal survival (Noble et al., 1984), continue to be expressed 
in these immortalized cells. Likewise, the expression of the 
p185 phosphoprotein is enhanced as compared to type 1 as- 
trocytes.  Very  recent studies indicate that A7-6.3  cells and 
type 1 astrocytes  also synthesize tranforming  growth factor 
13 (E. Van Obberghen-Schilling, T. Behar, M. B. Sporn, and 
M. Dubois-Dalcq, unpublished observations). Thus, A7-6.3 
immortalized cells may be a useful cell line to study various 
factors normally synthesized by type 1 astrocytes and/or the 
developing brain.  We expect that the A7 cell line and other 
stable immortalized cell lines are likely to be useful to study 
regulation  of cell-type specific gene expression in glial cells. 
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